In my cart

You have no items in your shopping cart.

6-Hydroxydopamine (6-OHDA) hydrobromide


Product overview

  • Name
    6-Hydroxydopamine (6-OHDA) hydrobromide
  • Short description
    Neurotoxin, widely used to produce the 6-OHDA Parkinson’s disease model
  • Biological description

    6-hydroxydopamine hydrobromide (6-OHDA) is widely used to lesion the nigrostriatal dopaminergic system as a model of Parkinson’s disease (6-OHDA lesion model).

    6-OHDA is commonly unilaterally administered into the medial forebrain bundle (MFB), substantia nigra or striatum to induce a selective depletion of dopamine neurons to reproduce behavioural deficits seen in Parkinson’s disease. Varying degrees of neurodegeneration occur depending on site of administration.

    Unilateral administration of 6-OHDA into one hemisphere (hemiparkinsonian model) permits assessment of a quantifiable turning behaviour which can be correlated with the magnitude of the nigrostriatal lesions. Bilateral 6-OHDA lesion models may also be used.

  • Alternative names
    6-OHDA, Oxidopamine
  • Biological action
  • Purity
  • Citations


  • Chemical name
    5-(2-Aminoethyl)-1,2,4-benzenetriol hydrobromide
  • Molecular Weight
  • Chemical structure
    6-Hydroxydopamine hydrobromide [636-00-0]
  • Molecular Formula
    C8H11NO3 · HBr
  • CAS Number
  • PubChem identifier
  • InChi
  • InChiKey
  • MDL number
  • Appearance
    Off-white solid

Storing and Using Your Product

  • Storage instructions
    Room temperature (desiccate)
  • Solubility overview
    Soluble in water (100 mM) and in DMSO (100 mM)
  • Handling
    This compound is air sensitive; exposure to air may affect compound performance. We therefore recommend storing the material in a sealed jar. Do not store the material in solution; make up solutions and use immediately.
  • Important
    This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

References for 6-Hydroxydopamine (6-OHDA) hydrobromide

  • A guide to neurotoxic animal models of Parkinson's disease.

    Tieu K (2011) Cold Spring Harb Perspect Med 1(1) : a009316
  • Unilateral Lesion of Dopamine Neurons Induces Grooming Asymmetry in the Mouse.

    Pelosi et al (2015) PLoS One 10(9) : e137185
    PubMedID: 26397369
  • Limitations of animal models of Parkinson's disease.

    Potashkin et al (2010) Parkinsons Dis 2011:658083 : 20
    PubMedID: 21209719
  • Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.

    Iancu et al (2005) Behav Brain Res. 162(1) : 1-10
    PubMedID: 15922062
Support & Resources

Reviews & Product Guides


  • Verified customer

    Works great and saves money!